The birth place of the type Ic Supernova 2007gr

We report our attempts to locate the progenitor of the peculiar type Ic SN 2007gr in HST pre-explosion images of the host galaxy, NGC 1058. Aligning adaptive optics Altair/NIRI imaging of SN 2007gr from the Gemini (North) Telescope with the pre-explosion HST WFPC2 images, we identify the SN position on the HST frames with an accuracy of 20 mas. Although nothing is detected at the SN position we show that it lies on the edge of a bright source, 134+/-23 mas (6.9 pc) from its nominal centre. Based on its luminosity we suggest that this object is possibly an unresolved, compact and coeval cluster and that the SN progenitor was a cluster member, although we note that model profile fitting favours a single bright star. We find two solutions for the age of this assumed cluster; 7-/+0.5 Myrs and 20-30 Myrs, with turn-off masses of 28+/-4 Msun and 12-9 Msun respectively. Pre-explosion ground-based K-band images marginally favour the younger cluster age/higher turn-off mass. Assuming the SN progenitor was a cluster member, the turn-off mass provides the best estimate for its initial mass. More detailed observations, after the SN has faded, should determine if the progenitor was indeed part of a cluster, and if so allow an age estimate to within ~2 Myrs thereby favouring either a high mass single star or lower mass interacting binary progenitor.Comment: 12 pages, 3 figures, resolution of fig 1. has been reduced, some revision based on referee's comments, Accepted ApJL 27 Nov 200

Repair of Torn Avascular Meniscal Cartilage Using Undifferentiated Autologous Mesenchymal Stem Cells:From In Vitro Optimization to a First-in-Human Study

Meniscal cartilage tears are common and predispose to osteoarthritis (OA). Most occur in the avascular portion of the meniscus where current repair techniques usually fail. We described previously the use of undifferentiated autologous mesenchymal stem cells (MSCs) seeded onto a collagen scaffold (MSC/collagen-scaffold) to integrate meniscal tissues in vitro. Our objective was to translate this method into a cell therapy for patients with torn meniscus, with the long-term goal of delaying or preventing the onset of OA. After in vitro optimization, we tested an ovine-MSC/collagen-scaffold in a sheep meniscal cartilage tear model with promising results after 13 weeks, although repair was not sustained over 6 months. We then conducted a single center, prospective, open-label first-in-human safety study of patients with an avascular meniscal tear. Autologous MSCs were isolated from an iliac crest bone marrow biopsy, expanded and seeded into the collagen scaffold. The resulting human-MSC/collagen-scaffold implant was placed into the meniscal tear prior to repair with vertical mattress sutures and the patients were followed for 2 years. Five patients were treated and there was significant clinical improvement on repeated measures analysis. Three were asymptomatic at 24 months with no magnetic resonance imaging evidence of recurrent tear and clinical improvement in knee function scores. Two required subsequent meniscectomy due to retear or nonhealing of the meniscal tear at approximately 15 months after implantation. No other adverse events occurred. We conclude that undifferentiated MSCs could provide a safe way to augment avascular meniscal repair in some patients. Registration: EU Clinical Trials Register, 2010-024162-22. © Stem Cells Translational Medicine 2016

Towards general-purpose neural network computing

Accepted manuscrip

Adolescent knee pain and patellar dislocations are associated with patellofemoral osteoarthritis in adulthood:A case control study

Background There is a lack of information about the association between patellofemoral osteoarthritis (PFOA) and both adolescent anterior knee pain (AKP) and previous patellar dislocations. Methods This case-control study involved 222 participants from our knee arthroplasty database answering a questionnaire. One hundred and eleven patients suffering from PFOA were 1:1 matched by gender with a unicompartmental tibiofemoral arthritis control group. Multivariate correlation and binary logistic regression analysis were performed, with odds ratios (ORs) and 95% confidence intervals (CIs) calculated. Results An individual is 7.5 times more likely to develop PFOA if they have suffered from adolescent AKP (OR 7.5, 95% CIs 1.51 to 36.94). Additionally, experiencing a patellar dislocation increases the likelihood of development of PFOA, with an adjusted odds ratio of 3.2 (95% CIs 1.25 to 8.18). A 44-year difference in median age of first dislocation was also observed between the groups. Conclusion This should bring into question the traditional belief that adolescent anterior knee pain is a benign pathology. Patellar dislocation is also a significant risk factor. These patients merit investigation, we encourage clinical acknowledgement of the potential consequences when encountering patients suffering from anterior knee pain or patellar dislocation. ©201

Towards General-Purpose Neural Network Computing

Machine learning is becoming pervasive, decades of research in neural network computation is now being leveraged to learn patterns in data and perform computations that are difficult to express using standard programming approaches. Recent work has demonstrated that custom hardware accelerators for neural network processing can outperform software implementations in both performance and power consumption. However, there is neither an agreed-upon interface to neural network accelerators nor a consensus on neural network hardware implementations. We present a generic set of software/hardware extensions, X-FILES, that allow for the general-purpose integration of feedforward and feedback neural network computation in applications. The interface is independent of the network type, configuration, and implementation. Using these proposed extensions, we demonstrate and evaluate an example dynamically allocated, multi-context neural network accelerator architecture, DANA. We show that the combination of X-FILES and our hardware prototype, DANA, enables generic support and increased throughput for neural-network-based computation in multi-threaded scenarios.Engineering and Applied Science

Programmable Smart Machines: A Hybrid Neuromorphic approach to General Purpose Computation

Engineering and Applied Science

Clustering in surgical trials : database of intracluster correlations

PMID: 22217216 [PubMed - indexed for MEDLINE] PMCID: PMC3311136 Free PMC ArticlePeer reviewedPublisher PD

Centre selection for clinical trials and the generalisability of results: a mixed methods study.

BACKGROUND: The rationale for centre selection in randomised controlled trials (RCTs) is often unclear but may have important implications for the generalisability of trial results. The aims of this study were to evaluate the factors which currently influence centre selection in RCTs and consider how generalisability considerations inform current and optimal practice. METHODS AND FINDINGS: Mixed methods approach consisting of a systematic review and meta-summary of centre selection criteria reported in RCT protocols funded by the UK National Institute of Health Research (NIHR) initiated between January 2005-January 2012; and an online survey on the topic of current and optimal centre selection, distributed to professionals in the 48 UK Clinical Trials Units and 10 NIHR Research Design Services. The survey design was informed by the systematic review and by two focus groups conducted with trialists at the Birmingham Centre for Clinical Trials. 129 trial protocols were included in the systematic review, with a total target sample size in excess of 317,000 participants. The meta-summary identified 53 unique centre selection criteria. 78 protocols (60%) provided at least one criterion for centre selection, but only 31 (24%) protocols explicitly acknowledged generalisability. This is consistent with the survey findings (n = 70), where less than a third of participants reported generalisability as a key driver of centre selection in current practice. This contrasts with trialists' views on optimal practice, where generalisability in terms of clinical practice, population characteristics and economic results were prime considerations for 60% (n = 42), 57% (n = 40) and 46% (n = 32) of respondents, respectively. CONCLUSIONS: Centres are rarely enrolled in RCTs with an explicit view to external validity, although trialists acknowledge that incorporating generalisability in centre selection should ideally be more prominent. There is a need to operationalize 'generalisability' and incorporate it at the design stage of RCTs so that results are readily transferable to 'real world' practice